LAUREN GASPARINI: Open Payments
NPI 1770008302 · LIVINGSTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$865 in 44 payments from 13 companies in 2025. Trend: 2023 $318 · 2024 $879 · 2025 $865
Food & beverage: $865
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $197 |
| Boston Scientific Corporation | 7 | $184 |
| SCILEX PHARMACEUTICALS INC. | 6 | $103 |
| SPR Therapeutics, Inc | 3 | $68 |
| Forte Bio-Pharma LLC | 4 | $65 |
| BIOTRONIK NRO, Inc. | 1 | $63 |
| Virtus Pharmaceuticals LLC | 2 | $34 |
| TerSera Therapeutics LLC | 2 | $33 |
| Collegium Pharmaceutical, Inc. | 2 | $30 |
| SI-BONE, INC. | 1 | $28 |
Products named: RELISTOR, General - Pain Management, SPRINT PNS System, ZTLido, PROLATE, Prospera, ELYXYB - CELECOXIB, LEVORPHANOL TARTRATE.
Industry payments across NJ — which companies pay providers there.
